BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Agastache Rugosa

115+ PubMed studies analyzed · 1 RCTs · Evidence Score: 31.8

Research Domains

Agastache Rugosa has been studied across 13 research domains including 🔬 Inflammation, 🔬 Oncology, 🫁 Liver & Detox, 🛡️ Immunity, 🧘 Stress & Anxiety. The primary research focus is 🔬 Inflammation with 17% of studies addressing this area.

Traditional Use (Ayurveda)

Known as huoxiang / 藿香 in Ayurveda. Virya (potency): Lung, Spleen, Stomach. Karma (actions): Dispels wind-water toxic swelling, Removes foul qi, Stops cholera with heart and abdominal pain, Key medicinal for Spleen and Stomach vomiting and counterflow, Aids Stomach qi, Opens the stomach orifice, Promotes intake of food and drink, Warms the Middle and moves qi freely, Treats Lung deficiency with cold, Treats congested heat in the Upper Burner, Treats bad breath from drinking alcohol by decocting and gargling.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Agastache Rugosa, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

paeonia
4975 shared targets
artemisia
5156 shared targets
Syzygium
5816 shared targets
commiphora
5399 shared targets
prunella
4972 shared targets
prunus
5905 shared targets
artemisia
5150 shared targets
epimedium
4746 shared targets
salvia
5719 shared targets
eriobotrya
5780 shared targets
Loading evidence profile...

This evidence profile for Agastache Rugosa is generated deterministically from 115 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.